Cited in boardrooms, legal proceedings & government briefings since 2017

In this report, Prohibition Partners and Teera Group explore the regulations and market developments in the most populous continent in the world.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
In this report, Prohibition Partners and Teera Group explore the regulations and market developments in the most populous continent in the world. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.
PDF + data
delivery format
2022
published
Cannabis is undergoing a process of re-liberalisation in Asia, where the damaging drug control policies, which have been pushed for decades, are receding in favour of more sensible, supportive and economically sound policies. While full legalisation is underway across much of North America and Europe, the legalisation of cannabis and its derivatives is occurring more gradually in Asia. The health and financial benefits of cannabis legalisation in North America are serving as an example to governments in Asia, and across the world, that the prohibition of cannabis is no longer a politically justifiable position to maintain. This is convincing more and more governments in Asia to reapraise their national drug strategies. COVID-19 was a catalyst for cannabis adoption during the pandemic, with countries, such as India noting increased usage among its citizens to combat stress and anxiety during challenging times. Cannabis is also seen as a new economic opportunity for many countries following the global lockdown, when the economy, exports and travel were brought to a standstill. Cannabis promises a brand new industry which will generate billions of dollars for several countries in the world in the near future. While this opportunity exists now, competition from many regions is increasing, and countries seeking to export, need to carefully consider the number of competitors, as well as supply and demand balances in target markets. Thailand is at the leading edge of cannabis liberalisation in South East Asia. The region decriminalised medical cannabis in 2018 and the country then decriminalised cannabis plant parts in a push towards commercialisation in June 2022. For a full exploration of cannabis liberalisation in Asia in Thailand see the Business In-sights into the Thai Cannabis Market Report available alongside this report.
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.